Growing community of inventors

Gyeonggi-do, South Korea

Young Mi Choi

Average Co-Inventor Count = 12.30

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Young Mi ChoiSung Jun Park (2 patents)Young Mi ChoiYoung Jun Park (2 patents)Young Mi ChoiSeung Suh Hong (2 patents)Young Mi ChoiEun Joo Cho (2 patents)Young Mi ChoiHyunnam Song (2 patents)Young Mi ChoiJong-hyoup Lee (2 patents)Young Mi ChoiJoon Hun Choi (2 patents)Young Mi ChoiJin-kyo Jeong (2 patents)Young Mi ChoiKyoung Suk Kim (1 patent)Young Mi ChoiMin Seob Lee (1 patent)Young Mi ChoiYeon Jung Kim (1 patent)Young Mi ChoiMinseob Lee (1 patent)Young Mi ChoiMatthew Sangyup Lee (1 patent)Young Mi ChoiIn-Suk Lee (1 patent)Young Mi ChoiJin Seo Lee (1 patent)Young Mi ChoiJoon Woo Kim (1 patent)Young Mi ChoiJin-Kyo Jeong (0 patent)Young Mi ChoiYoung Mi Choi (2 patents)Sung Jun ParkSung Jun Park (466 patents)Young Jun ParkYoung Jun Park (31 patents)Seung Suh HongSeung Suh Hong (5 patents)Eun Joo ChoEun Joo Cho (3 patents)Hyunnam SongHyunnam Song (2 patents)Jong-hyoup LeeJong-hyoup Lee (2 patents)Joon Hun ChoiJoon Hun Choi (2 patents)Jin-kyo JeongJin-kyo Jeong (2 patents)Kyoung Suk KimKyoung Suk Kim (2 patents)Min Seob LeeMin Seob Lee (2 patents)Yeon Jung KimYeon Jung Kim (2 patents)Minseob LeeMinseob Lee (1 patent)Matthew Sangyup LeeMatthew Sangyup Lee (1 patent)In-Suk LeeIn-Suk Lee (1 patent)Jin Seo LeeJin Seo Lee (1 patent)Joon Woo KimJoon Woo Kim (1 patent)Jin-Kyo JeongJin-Kyo Jeong (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Celltrion Inc. (2 from 30 patents)


2 patents:

1. 9814784 - Antibody-linker-drug conjugate, preparation method therefor, and anticancer drug composition containing same

2. 9278996 - Dolastatin-10 derivative, method of producing the same and anticancer drug composition containing the same

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/31/2025
Loading…